Home > News > Top Stories > Anatomy IT Enhances Value-Based Care Services Through Acquisition of MIPS Business Unit from MarsdenAdvisors

Health Technology, Healthcare Analytics

Anatomy IT Enhances Value-Based Care Services Through Acquisition of MIPS Business Unit from MarsdenAdvisors

Anatomy IT Enhances

Anatomy IT, the leading platform for healthcare IT and cybersecurity solutions, announced the acquisition of the Merit-Based Incentive Payment System (MIPS) business unit from MarsdenAdvisors, a leading healthcare solutions and consulting company. This strategic acquisition enables Anatomy IT to broaden its range of Advisory solutions, providing enhanced value and support to its customers in navigating the complex MIPS system.

“The addition of MarsdenAdvisors’ MIPS bolsters Anatomy IT’s ability to deliver unparalleled support to our customers with expert healthcare technology guidance, cybersecurity leadership, and now value-based care expertise,” said Frank Forte, CEO of Anatomy IT. “By expanding Anatomy IT’s Advisory Suite, we further strengthen our mission of providing innovative solutions to our customers that empower exceptional patient care across the care continuum."

The addition of MIPS value-based care expertise to Anatomy IT’s already robust Advisory Suite reinforces its commitment to simplifying the complex by offering high-quality, cost-effective solution bundles that maximize value for healthcare providers. This acquisition aligns with Anatomy IT's unwavering commitment to improving quality and promoting transparency in performance. It will assist healthcare organizations in operating at their highest potential and enhance the company's capacity to provide the necessary technology, tools, and guidance that healthcare providers need to excel in the ever-changing healthcare industry.

"We are thrilled to join the Anatomy IT team and embark on this exciting journey together,” said Randy Marsden, Founder/Owner MarsdenAdvisors. “Both companies share a common vision for healthcare technology. Together, we are poised to make a significant impact for healthcare providers and drive positive change in patient care."

About Anatomy IT

Anatomy IT helps healthcare providers deliver exceptional patient care through technology and cybersecurity solutions. With 30+ years of experience, we understand healthcare organizations' unique risks, opportunities, and challenges. Anatomy IT is one of the largest and fastest-growing healthcare IT companies, partnering with 1,100+ clients serving 32,000+ healthcare staff nationwide, including ASCs, physician groups, and hospitals.

About MarsdenAdvisors

MarsdenAdvisors is a healthcare solutions company helping practices run their very best. Through EHR (Electronic Health Record) consulting, MIPS (Merit-Based Incentive Payment System) management, and data migration, we equip our clients with the tools and know-how to accelerate their practices into the future.

Spotlight

More featured news

Spotlight

Related News

Health Technology

Alameda Healthcare Group and Medtronic Unveil Neuroscience Center

Medtronic | November 08, 2023

Alameda Healthcare Group, in partnership with Medtronic, has launched a Neuroscience Center of Excellence to enhance patient care in Egypt and nearby areas. This initiative introduces the StealthStation S8 Surgical Navigation System to revolutionize surgical procedures and enhance clinical outcomes. The Alameda-Medtronic partnership is set to enhance patient care, aligning with Alameda's mission to improve healthcare and solidifying its pioneering role. Alameda Healthcare Group, a premier private healthcare service provider in Egypt, has announced the inauguration of its Neuroscience Center of Excellence, a collaborative effort with Medtronic, a renowned leader in healthcare technology solutions. At the inauguration of the Neuroscience Center of Excellence, esteemed speakers elaborated on the significant role anticipated for the StealthStation S8 Surgical Navigation System in advancing the field of neurosurgery. Meanwhile, Dr. Ramy Amin, Professor of Neurosurgery at Cairo University, led a panel discussion during the launch event. The panel also featured some of the renowned medical consultants, leading neurosurgeons, as well as neurologists. Additionally, Professor Hossam Salah, the Dean of the Faculty of Medicine at Cairo University, graced the event as the guest of honor. The panel discussion explored the pivotal role that this new center is poised to play in enhancing key aspects of neurosurgery. It also commended Alameda's dedication to elevating the quality of patient care through the integration of innovative technology. Neeraj Mishra, Group CEO of Alameda Healthcare, remarked. This partnership represents a substantial step forward in setting new standards for healthcare excellence in Egypt, and we look forward to the benefits it will bring to the patients Alameda continues to serve. [Source – Zawya] He also stated that establishing the Neuroscience Center of Excellence shows Alameda's commitment to advancing technology and raising healthcare standards in Egypt and the surrounding region. With this strategic partnership, Alameda Healthcare Group can incorporate Medtronic's advanced technology into its new center of excellence, thereby bringing about a substantial enhancement in surgical procedures and ultimately improving patient outcomes. Through real-time tracking and advanced imaging capabilities, this technology will enable neurosurgeons to steer complex surgical procedures with heightened precision, thereby enhancing patient results. It will also provide surgeons with various advanced features, including precise imaging, guidance, and different essential surgical tools. The partnership between Alameda Healthcare Group and Medtronic will provide patients with advanced, precise, and patient-focused surgical care. This perfectly aligns with Alameda's mission to improve healthcare for everyone, reinforcing its position as a pioneer in the healthcare industry.

Read More

Medical Devices

GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers

Business Wire | October 30, 2023

GE HealthCare and reLink Medical announced a collaboration to deliver asset management solutions to healthcare providers to help reduce medical device waste, increase operational efficiency and maximize their equipment utilization. This collaboration features a standardized medical equipment disposition solution involving selling, recycling or donating equipment that is no longer needed. Each year, healthcare providers retire approximately ten percent of their medical assets from use.2 Attempting to manage medical device waste independently can often require staff time and create cumbersome processes filled with hidden costs. As providers continue to face cost pressures from the COVID-19 pandemic, managing budgets and uncovering cost savings is a priority. said Mohamed El-Demerdash, President, U.S. & Canada Service, GE HealthCare. A potential and often overlooked source of expense for providers is medical device waste, which includes aging, or end-of-life, medical devices that sit idle in a healthcare provider’s inventory. With this collaboration, GE HealthCare will help healthcare providers manage their clinical devices for the full lifecycle of their equipment, a true wing-to-wing solution, from capital planning and purchasing to maintenance and final disposition of the equipment. [Source:Business Wire] When the disposition solution entails selling the medical equipment, a percentage of the revenue from that sale is returned to the healthcare provider in the form of credits that they can use to purchase equipment or parts, invest in training for their technicians and engineers, purchase On-Demand services including deinstallations or specific hospital modernization projects, or redeem the revenue via a wire transfer or check from reLink Medical. Sustainability is an important consideration for the management of end-of-life equipment. More than six million pounds of medical waste are kept out of landfills each year through reLink Medical’s processes.3 This collaboration between GE HealthCare and reLink Medical is aimed at supporting healthcare providers in disposing medical equipment in a safe, compliant and environmentally responsible manner and it further advances GE HealthCare and reLink Medical’s commitment to sustainability. Efficiency Gains Through Managing Equipment Surplus In addition to managing the disposition of end-of-life medical devices, as part of this collaboration GE HealthCare and reLink Medical can transport equipment for redeployment between clinical sites and provide long-term storage of equipment for healthcare providers at offsite locations through a smart warehouse solution. This solution will manage logistics to simplify pick up of medical devices from a healthcare provider’s site and catalog every device so providers have a clear understanding of where their assets are located, helping to ensure they have the medical equipment they need without bearing the burden of storing and managing surplus inventory. “This collaboration signifies a significant step forward in revolutionizing asset management solutions and empowering healthcare organizations with the tools and technologies needed to optimize their equipment utilization,” said Jeff Dalton, CEO, reLink Medical. “It leverages reLink Medical’s expertise in equipment disposition, surplus management and inventory optimization to complement GE HealthCare’s comprehensive suite of healthcare solutions.”

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

Health Technology

Alameda Healthcare Group and Medtronic Unveil Neuroscience Center

Medtronic | November 08, 2023

Alameda Healthcare Group, in partnership with Medtronic, has launched a Neuroscience Center of Excellence to enhance patient care in Egypt and nearby areas. This initiative introduces the StealthStation S8 Surgical Navigation System to revolutionize surgical procedures and enhance clinical outcomes. The Alameda-Medtronic partnership is set to enhance patient care, aligning with Alameda's mission to improve healthcare and solidifying its pioneering role. Alameda Healthcare Group, a premier private healthcare service provider in Egypt, has announced the inauguration of its Neuroscience Center of Excellence, a collaborative effort with Medtronic, a renowned leader in healthcare technology solutions. At the inauguration of the Neuroscience Center of Excellence, esteemed speakers elaborated on the significant role anticipated for the StealthStation S8 Surgical Navigation System in advancing the field of neurosurgery. Meanwhile, Dr. Ramy Amin, Professor of Neurosurgery at Cairo University, led a panel discussion during the launch event. The panel also featured some of the renowned medical consultants, leading neurosurgeons, as well as neurologists. Additionally, Professor Hossam Salah, the Dean of the Faculty of Medicine at Cairo University, graced the event as the guest of honor. The panel discussion explored the pivotal role that this new center is poised to play in enhancing key aspects of neurosurgery. It also commended Alameda's dedication to elevating the quality of patient care through the integration of innovative technology. Neeraj Mishra, Group CEO of Alameda Healthcare, remarked. This partnership represents a substantial step forward in setting new standards for healthcare excellence in Egypt, and we look forward to the benefits it will bring to the patients Alameda continues to serve. [Source – Zawya] He also stated that establishing the Neuroscience Center of Excellence shows Alameda's commitment to advancing technology and raising healthcare standards in Egypt and the surrounding region. With this strategic partnership, Alameda Healthcare Group can incorporate Medtronic's advanced technology into its new center of excellence, thereby bringing about a substantial enhancement in surgical procedures and ultimately improving patient outcomes. Through real-time tracking and advanced imaging capabilities, this technology will enable neurosurgeons to steer complex surgical procedures with heightened precision, thereby enhancing patient results. It will also provide surgeons with various advanced features, including precise imaging, guidance, and different essential surgical tools. The partnership between Alameda Healthcare Group and Medtronic will provide patients with advanced, precise, and patient-focused surgical care. This perfectly aligns with Alameda's mission to improve healthcare for everyone, reinforcing its position as a pioneer in the healthcare industry.

Read More

Medical Devices

GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers

Business Wire | October 30, 2023

GE HealthCare and reLink Medical announced a collaboration to deliver asset management solutions to healthcare providers to help reduce medical device waste, increase operational efficiency and maximize their equipment utilization. This collaboration features a standardized medical equipment disposition solution involving selling, recycling or donating equipment that is no longer needed. Each year, healthcare providers retire approximately ten percent of their medical assets from use.2 Attempting to manage medical device waste independently can often require staff time and create cumbersome processes filled with hidden costs. As providers continue to face cost pressures from the COVID-19 pandemic, managing budgets and uncovering cost savings is a priority. said Mohamed El-Demerdash, President, U.S. & Canada Service, GE HealthCare. A potential and often overlooked source of expense for providers is medical device waste, which includes aging, or end-of-life, medical devices that sit idle in a healthcare provider’s inventory. With this collaboration, GE HealthCare will help healthcare providers manage their clinical devices for the full lifecycle of their equipment, a true wing-to-wing solution, from capital planning and purchasing to maintenance and final disposition of the equipment. [Source:Business Wire] When the disposition solution entails selling the medical equipment, a percentage of the revenue from that sale is returned to the healthcare provider in the form of credits that they can use to purchase equipment or parts, invest in training for their technicians and engineers, purchase On-Demand services including deinstallations or specific hospital modernization projects, or redeem the revenue via a wire transfer or check from reLink Medical. Sustainability is an important consideration for the management of end-of-life equipment. More than six million pounds of medical waste are kept out of landfills each year through reLink Medical’s processes.3 This collaboration between GE HealthCare and reLink Medical is aimed at supporting healthcare providers in disposing medical equipment in a safe, compliant and environmentally responsible manner and it further advances GE HealthCare and reLink Medical’s commitment to sustainability. Efficiency Gains Through Managing Equipment Surplus In addition to managing the disposition of end-of-life medical devices, as part of this collaboration GE HealthCare and reLink Medical can transport equipment for redeployment between clinical sites and provide long-term storage of equipment for healthcare providers at offsite locations through a smart warehouse solution. This solution will manage logistics to simplify pick up of medical devices from a healthcare provider’s site and catalog every device so providers have a clear understanding of where their assets are located, helping to ensure they have the medical equipment they need without bearing the burden of storing and managing surplus inventory. “This collaboration signifies a significant step forward in revolutionizing asset management solutions and empowering healthcare organizations with the tools and technologies needed to optimize their equipment utilization,” said Jeff Dalton, CEO, reLink Medical. “It leverages reLink Medical’s expertise in equipment disposition, surplus management and inventory optimization to complement GE HealthCare’s comprehensive suite of healthcare solutions.”

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

More featured news